Artery Roadshow Session 5: Empowering Smart Healthcare – Innovative Companies to Watch!

The rapid innovation of internet technology has also opened new breakthroughs for the development of the healthcare industry. Traditional healthcare is transitioning toward smart healthcare, with internet hospitals, artificial intelligence, cloud computing, and blockchain applications all becoming hot topics in the industry. Under the dual focus of investment and regulation, how will practitioners in smart healthcare seize this new opportunity and successfully address this new challenge?

This week, VCBeat’s Roadshow Hall has curated five standout projects. Let’s take a look at the efforts practitioners have made to build “more efficient, more convenient, and smarter” healthcare services.

Blockchain, Electronic Prescription Circulation System, Medical Big Data

Yilian Group is a healthcare big data company built on blockchain technology. The Group currently operates three major business segments: B2C, B2B, and B2G. It leverages blockchain technology to assist more healthcare entities in their digital transformation and upgrading, helps medical institutions break down data silos to achieve data interconnectivity and information sharing, establishes a permanent electronic health record for every individual, and utilizes artificial intelligence technology for proactive disease prevention.

The blockchain-based electronic prescription circulation system is one of the ten component systems of the smart healthcare information system.

Integrating traditional healthcare with internet technology to create a dedicated online hospital campus, and connecting pharmacies, hospitals, pharmaceutical manufacturers, government agencies, distributors, and logistics providers through the “Five-Step Empowerment Method.” This approach increases retail pharmacy sales, reduces the proportion of pharmaceutical revenue in hospitals, facilitates bidirectional referral of prescriptions and patients, and achieves multi-party win-win outcomes.

Currently, the platform has been designated by the Shaanxi Provincial Medical Products Administration as the sole pilot unit for remote prescription review in Shaanxi Province, and it is also the first authorized and promoted electronic prescription sharing platform in China.

Funding Plan: Series A

Funding Requirement: 20 million

“With 101 Blockchain Invention Patents, How MedChain Group Leverages Blockchain Technology to Tap into the Trillion-Yuan Prescription Outflow Market”

https://vcbeat.top/Y2QzMTk5MTQxZWQ4YWM3MzVhYWJmZTY3NjE0NjBiZmM=

Technology is the core advantage of Yilian Group. The company currently has 70 technical development personnel, and has applied for 23 computer software copyrights, 41 blockchain invention patents, 11 utility model patents, 4 design patents, 63 trademark registrations, and 12 copyright registrations. In addition, as an important component of healthcare reform, the outflow of prescriptions has always been a key focus for relevant authorities, with many provinces and cities previously issuing documents explicitly calling for the establishment of prescription circulation platforms.

Internet Doctor Cloud Clinic, Offline Smart Shared Center

Zhongrong Runda (Beijing) Investment Co., Ltd. specializes in digital and smart internet hospital services, with a focus on the fields of dentistry and medical aesthetics. By leveraging its unique business model and partnership program, combined with internet-based information management tools, the company is committed to building a leading doctor-centric smart healthcare platform in China. Since its establishment in 2011, the company has acquired three subsidiaries and four physical medical institutions, and has signed contracts with a cumulative total of 3,000 medical aesthetic physicians and 2,000 dental physicians.

# Renowned Physicians’ Digital Smart Chain SystemThe Renowned Physicians’ Digital Smart Chain System, a key corporate initiative, integrates offline physical shared hospital chains, online digital smart cloud clinics, and an intelligent physician credit system platform. Leveraging technical support from smart terminals, intelligent software, and IoT devices, the project has established a comprehensive physician service ecosystem. This system maximizes physicians’ professional value while enhancing patient consultation efficiency, thereby providing an empowerment platform for the upstream dental industry chain.

Financing Plan: Series A Financing

Financing Amount: RMB 30 million

Use of Proceeds: Expansion of offline institutions and expansion of the online internet hospital operations team

Funding History: First Round

“Meixin Shengdiya: China’s First Internet Hospital for Medical Aesthetics—The Next Hotspot for Capital Investment?”

https://vcbeat.top/NzEwMTkzNzBjZGIzMTJhZTYzYmI3OGNmOTgzYmU2MDk=

Zhongrong Meixin has obtained China’s first internet hospital license in the dental sector. In 2017, the market size of China’s internet healthcare industry reached RMB 33.5 billion, and is projected to reach RMB 90 billion by 2020. Investment institutions interested in smart micro-clinics that integrate online and offline services may contact Xiao Yun for more project information.

Digital Dentistry, Dental Instruments, Dental Implants

Kerunxi Medical is a company centered on the sales of medical devices, which has gradually evolved into an integrated enterprise encompassing research and development, manufacturing, sales, and application. The company integrates dental implant instruments, dental implant systems, digital restoration, and oral digital design and processing centers, providing clinical dental institutions and denture processing facilities with design services, digital products, and related professional training. Its two production bases in Nanjing and Zhengzhou are equipped with domestically leading modern processing conditions and testing methods.

The company has established strong collaborative partnerships with prestigious institutions such as Nanjing University, Nanjing Medical University, and Southeast University, jointly conducting preliminary research and experimental development on multiple products. Its main product portfolio includes the Apex Implant System, the Credit Implant System, dental implant surgical instruments, and comprehensive digital implantology solutions.

Funding Plan: Pre-A Round Financing

Financing Amount: RMB 50-70 million

Use of Funds: Market Expansion, Capacity Expansion, Product R&D

Project Valuation: 700 Million

The rise of digital dentistry concepts, coupled with shifting consumer trends, has led to greater consumer emphasis on oral health prevention and management. The promotion and application of digital dentistry are gradually disrupting the traditional dental industry. However, investment capital remains concentrated in downstream service sectors, leaving substantial room for investment in the upstream segment of the dental industry where manufacturers operate.

Data Aggregation, High-Efficiency Computing, and Research Empowerment

Hualian Medical was established in Jinan, Shandong Province, in 2018 with the mission of serving medical and clinical research, striving to build a globally leading integrated platform for medical big data. Since its inception, Hualian Medical has developed deep expertise in big data and blockchain technologies. Its core team has achieved significant success in transforming medical data into high-quality clinical research. In the summer of 2018, in collaboration with Shandong University and the Shizhong District Government of Jinan City, Hualian Medical established the Hualian Medical Innovation Center, creating a specialized hub for clinical research translation and enterprise incubation.

The Hualian Health Data Integrated Platform comprises a data aggregation platform, a high-performance computing platform, a cloud-based research platform, and a health applications platform. It empowers hospitals to enhance their research capabilities, provides electronic medical record (EMR) data services, and offers operational decision support; facilitates scientific research at universities and colleges; supports government agencies with resident health status analysis, policy-making, and the development of the health big data industry; and enters the insurtech sector by providing analytical support for medical insurance repricing and actuarial services.

Financing Plan: Pre-A Round Financing

Financing Amount: RMB 5-10 million

Use of Funds: Product Development, Market Promotion

Financing History: First Round of Financing

“How Does Hualian Medical Leverage Big Data and Blockchain Underlying Technologies to Address the Pain Points in Medical Research Data?”

https://vcbeat.top/NTgxYjkxZjU2YjEwMGU4YzUyNWE5OWFhZTAyZjY1OTk=

One of Hualian Medical’s core strengths is its professional research team, comprising the Institute of Medical Health Big Data at Shandong University and the Medical Big Data Blockchain Research Center. Facilitating the translation of academic research into practical applications is also a key priority supported by relevant national ministries and commissions. Investment firms that focus on the medical big data sector and prioritize R&D teams can contact Xiao Yun to learn more about project details.

Dermatology, Big Data, and AI Diagnosis

Dingshi Intelligence is dedicated to applying the most advanced artificial intelligence technologies and deep learning algorithms throughout the entire process of dermatological diagnosis and treatment. The company has established collaborations with numerous leading hospitals and dermatology departments in China, and has built industry-academia-research platforms with top-tier computer science institutions both domestically and internationally, including the University of Washington, Tsinghua University, and Peking University. Its mission is to create a “Smart Dermatology” system for the era of artificial intelligence.

The “Wending Skin SkinReader” intelligent diagnostic system, developed by the company, comprises subsystems such as Wending Skin Cloud, dermoscopic diagnostic system, dermatological photography diagnostic system, skin CT diagnostic system, dermatopathology diagnostic system, cutaneous ultrasound diagnostic system, patient management, and case management. Tailored to the actual needs of hospital dermatology departments, the platform can be assembled in a modular, “building-block” fashion and flexibly expanded, thereby empowering hospital dermatology departments with robust AI-driven diagnostic capabilities and achieving a win-win outcome for hospitals, physicians, and patients.

Financing History: 2 rounds (the first round was capital contribution by founding shareholders, and the second round was investment by individual investors)

Funding Requirement: 10 million

Use of Funds: Market Expansion, Product Enhancement, Class III Medical Device Registration

“After Winning the ISIC Skin AI Competition, What Business Models Has Dingshi Intelligence Explored?”

https://vcbeat.top/NDVjMjgyZTg3NWY2NjEzNzgxMjk1OWIwNTA4YzY4NmM=

In August 2019, Dingshi Zhihui secured first place in the ISIC 2019, a top-tier global medical imaging algorithm competition (based on public data). Additionally, its high-quality, standardized dermoscopic image library ranks first worldwide in terms of volume among known skin image databases for individuals of East Asian descent. Investment institutions with an interest in the medical devices plus software sector, or in AI-based diagnosis of dermatological conditions, are invited to contact Xiao Yun for project inquiries.

To date, VCBeat Roadshow Hall has launched five sessions, presenting a total of 25 projects. We extend our sincere gratitude to all participating project teams and investment institutions for their support of VCBeat Roadshow Hall. We remain committed to identifying high-quality projects and delivering superior content through more diverse roadshow formats, thereby building an effective bridge for information exchange between investors and fundraisers.